Efficacy of adalimumab therapy for life-threatening pulmonary vasculitis in Beh‡et's disease

被引：18

作者：

Aamar, Suhail ^{[1
]}

Peleg, Hagit ^{[1
]}

Leibowitz, David ^{[1
]}

Chajek-Shaul, Tova ^{[1
]}

Hiller, Nurith ^{[2
]}

Heyman, Samuel N. ^{[1
]}

机构：

[1] Hadassah Hebrew Univ Hosp, Dept Med, IL-91240 Jerusalem, Israel

[2] Hadassah Hebrew Univ Hosp, Dept Radiol, IL-91240 Jerusalem, Israel

来源：

RHEUMATOLOGY INTERNATIONAL | 2014年 / 34卷 / 06期

关键词：

Behcet's disease; Adalimumab; Aneurysm; Pulmonary artery; Thrombus; Heart ventricle; Positron emission tomography; BEHCETS-DISEASE; INFLIXIMAB; POLYMORPHISMS; ANEURYSMS; FAILURE; ULCERS;

D O I：

10.1007/s00296-013-2693-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Inflammatory large-vessel vasculitis in Beh double dagger et's disease may cause life-threatening arterial aneurysms that are prone to rupture. We report a patient with Beh double dagger et's disease with right ventricular thrombus and large aneurysms of the pulmonary arteries that led to recurrent episodes of hemoptysis. Following relapses and only partial response to repeated courses of cyclophosphamide and steroids, the patient was treated with adalimumab (Humira) and is now in clinical remission for over 30 months, with regression of her pulmonary lesions. Anti-TNF alpha treatment is a potential therapeutic option in patients with life-threatening complications due to large-vessel vasculitis.

引用

页码：857 / 860

页数：4

共 19 条

[1] Behcet's disease: Successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis [J].

Adler, Sabine ;

Baumgartner, Iris ;

Villiger, Peter M. .

ARTHRITIS CARE & RESEARCH, 2012, 64 (04) :607-611

[2] Mapping the HLA association in Behcet's disease - A role for tumor necrosis factor polymorphisms? [J].

Ahmad, T ;

Wallace, GR ;

James, T ;

Neville, M ;

Bunce, M ;

Mulcahy-Hawes, K ;

Armuzzi, A ;

Crawshaw, J ;

Fortune, F ;

Walton, R ;

Stanford, MR ;

Welsh, KI ;

Marshall, SE ;

Jewell, DP .

ARTHRITIS AND RHEUMATISM, 2003, 48 (03) :807-813

[3]

Atzeni F, 2010, CLIN EXP RHEUMATOL, V28, pS94

[4] Behcet's disease with life-threatening haemoptoe and pulmonary aneurysms: complete remission after infliximab treatment [J].

Baki, K. ;

Villiger, P. M. ;

Jenni, D. ;

Meyer, T. ;

Beer, J. H. .

ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (11) :1531-1532

[5] Cytokine inhibitors:: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behcet's disease [J].

Düzgün, N ;

Ayaslioglu, E ;

Tutkak, H ;

Aydintug, OT .

RHEUMATOLOGY INTERNATIONAL, 2005, 25 (01) :1-5

[6] Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet's disease [J].

Kamoun, Mariam ;

Chelbi, Hanene ;

Houman, Mohamed Habib ;

Lacheb, Jihene ;

Hamzaoui, Kamel .

HUMAN IMMUNOLOGY, 2007, 68 (03) :201-205

[7]

Leccese P, 2011, CLIN EXP RHEUMATOL, V29, pS93

[8]

Leccese P, 2010, CLIN EXP RHEUMATOL, V28, pS102

[9] Cardiac Behcet disease presenting as aortic vaivulitis/aortitis or right heart inflammatory mass: A clinicopathologic study of 12 cases [J].

Lee, Inchul ;

Park, Sohyung ;

Hivang, Seon ;

Kim, Mi-Jeong ;

Nah, Seong-Su ;

Yoo, Bin ;

Song, Jae-Kwan .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2008, 32 (03) :390-398

[10] Adalimumab treatment for life threatening pulmonary artery aneurysm in Behcet disease: a case report [J].

Lee, Sung-Won ;

Lee, Sang-Yeob ;

Kim, Ki-Nam ;

Jung, Jin-Kyu ;

Chung, Won-Tae .

CLINICAL RHEUMATOLOGY, 2010, 29 (01) :91-93

← 1 2 →